Clover Health Investments Crop. ($CLOV) Stock Forecast: Up 5.2% Today

What is Clover Health Investments Crop.?

Clover Health (CLOV) is a healthcare technology company that focuses on providing Medicare Advantage plans to seniors in the United States. The company aims to use data-driven insights to improve healthcare outcomes for its members.

Why is Clover Health Investments Crop. going up?

CLOV stock is up 5.2% on Apr 22, 2026 16:50

• The positive sentiment surrounding CLOV stock today may be linked to executives having shares withheld for tax obligations related to the vesting of restricted stock units (RSUs), signaling confidence in the company's future growth.
• Tax-related share withholding actions by top executives, including the CEO, CFO, and Chief Legal Officer, may have bolstered investor trust in the leadership team's dedication to long-term success, boosting investor confidence and elevating the stock price.
• These transactions reflect transparency and adherence to tax regulations, potentially boosting the company's reputation and credibility with investors and stakeholders, fueling the bullish market movement in CLOV stock today.

CLOV Price Chart

CLOV Technical Analysis

CLOV News

Clover Health (CLOV) CEO RSU vesting triggers share tax withholding

Brady Patrick Priest, CEO of Clover Care Services, underwent a routine tax-withholding transaction where 36,113 Clover Health Investments Class A Common Stock shares were withheld at $2.19 each. This was to cover tax obligations from vested restricted stock units (RSUs). This transaction is a compensation-related tax settlement and not an open-market sale, leaving Priest with 2,138,261 shares.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-81572eef7d4f.html

Clover Health (CLOV) executive stock withheld to cover RSU tax bill

Clover Health Investments executive Brady Patrick Priest had 15,471 shares of Class A Common Stock withheld at $2.04 per share to cover tax obligations related to the vesting of restricted stock units (RSUs). This was an automatic tax-withholding event, not an open-market sale, and relates to 6.25% of an RSU grant from October 2024. Following the transaction, Priest directly holds 2,174,374 Class A shares, with remaining RSUs vesting quarterly until October 2028.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-29b4d3058edf.html

Clover Health (CLOV) CLO reports RSU tax-withholding transaction

Clover Health Investments' Chief Legal Officer, Karen Soares, reported a tax-related share withholding for Restricted Stock Units (RSUs). On April 15, 2026, 10,161 shares were withheld at $2.04 per share to cover tax obligations upon the vesting of 6.25% of an RSU award. Soares now directly holds 1,572,422 shares of Clover Health Class A Common Stock.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-d57065931e66.html

Clover Health (CLOV) interim CFO has RSU tax shares withheld in Form 4

Clover Health's Interim CFO, Joseph Clay, reported a routine tax-withholding event related to restricted stock units (RSUs) on April 15, 2026. A total of 4,158 shares of Class A Common Stock were automatically withheld at $2.04 per share to cover taxes upon the vesting of 6.25% of an RSU grant. Clay now directly holds 1,234,526 shares of Class A Common Stock, with remaining RSUs vesting quarterly through October 15, 2028, subject to his continued service.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-baf473f18742.html

Clover Health (CLOV) CEO has 60,765 shares withheld for RSU tax on vesting

Clover Health Investments CEO Andrew Toy had 60,765 shares of Class A Common Stock withheld at $2.04 per share on April 15, 2026, to cover tax obligations arising from the vesting of Restricted Stock Units (RSUs). This transaction, a routine tax-related disposition, leaves Toy with 10,009,005 shares directly owned. The withholding relates to 6.25% of an RSU grant from October 2024, with remaining RSUs vesting quarterly until October 2028 contingent on his continued service.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-74910e1c4f1a.html

Trending Today

Circle Internet Group ($CRCL) Stock Forecast: Up 5.0% Today

FuelCell Energy ($FCEL) Stock Forecast: Up 19.4% Today

Booking Holdings Inc. ($BKNG) Stock Forecast: Down 6.7% Today

Optimism ($OP) Crypto Forecast: Up 5.1% Today

Sunrun Inc. ($RUN) Stock Forecast: Up 5.1% Today

T-Mobile US Inc. ($TMUS) Stock Forecast: Down 8.2% Today

PVH Corp. ($PVH) Stock Forecast: Down 5.1% Today

ARM Holdings plc ($ARM) Stock Forecast: Up 10.6% Today

Gasoline ($GASOLINE) Commodity Forecast: Up 5.6% Today

United Continental Holdings Inc. ($UAL) Stock Forecast: Down 7.3% Today

Clover Health Investments Crop. Price History

02.03.2026 - CLOV Stock was up 6.0%

• The rise in CLOV stock today could be linked to the announcement of an upcoming CFO transition. Despite this change, the company reiterated its financial outlook for 2026, which likely boosted investor confidence in its strategy and financial health.
• Although Vanguard reported holding zero shares in Clover Health, causing initial concerns, the market sentiment appeared to shift positively due to the company's reaffirmed financial guidance and growth prospects.
• An AI Analyst rated CLOV stock as Neutral citing a mix of financial quality and technical pressures, which may have dampened some market enthusiasm. However, the focus on membership growth and profitability goals likely balanced this, contributing to the observed bullish trend.

21.03.2026 - CLOV Stock was up 10.2%

• The bullish movement in CLOV's stock today is possibly influenced by executives' decision to withhold shares for tax obligations relating to the vesting of restricted stock units (RSUs), showcasing confidence in the company's future performance.
• Routine tax-related dispositions by key executives, including the CEO, CFO, and Chief Legal Officer, reflect their dedication to Clover Health's long-term success, likely bolstering investor confidence.
• These transactions could be seen as a positive display of transparency and sound financial management, potentially contributing to the upward momentum in CLOV's stock price.
• Overall, the market's favorable reaction to the executives' actions hints at their trust in Clover Health's growth potential and financial stability.

18.02.2026 - CLOV Stock was down 5.1%

• Executives at Clover Health, including Jamie L. Reynoso and Conrad Wai, had shares withheld to cover tax obligations related to vested restricted stock units (RSUs).
• The automatic withholding of shares for tax purposes may have led to increased selling pressure on the stock, contributing to the bearish movement.
• Investors might interpret the executives' actions as a lack of confidence in the company's future performance, further dampening market sentiment towards Clover Health.
• The series of tax-related share withholdings could have signaled potential concerns about the company's financial health or regulatory challenges, prompting investors to react bearishly.

22.00.2026 - CLOV Stock was up 5.3%

• The rise in CLOV stock could be linked to the CEO's recent share sales, potentially indicating confidence in the company's future.
• Upbeat forecasts for profitability in 2026 and an annual increase in Medicare Advantage membership likely boosted investor confidence and led to the stock's upward movement.
• Despite a lack of profitability over the past year, the expectation of turning profitable this year and being deemed slightly undervalued by InvestingPro could have additionally stimulated investor interest in CLOV.

04.02.2026 - CLOV Stock was up 6.8%

• The company recorded remarkable 40% revenue growth in 2025, hitting $1.9 billion, and saw a 38% increase in its Medicare Advantage membership to 113,803. This strong financial performance likely influenced the stock's positive movement.
• Despite reporting a GAAP net loss in 2025, Clover Health achieved non-GAAP profitability, indicating effective operational practices and cost control measures.
• Clover Health's forecast of achieving GAAP net income profitability in 2026, coupled with revenue guidance ranging between $2.81 billion and $2.92 billion, presented a promising future for investors, driving bullish sentiment in the market.
• The company's strategic efforts, including enhancements to its Clover Assistant platform, expansion into new regions, and introduction of new products, showcase its dedication to growth and innovation, further enhancing investor trust in the stock.

06.10.2025 - CLOV Stock was down 7.2%

• Highlighting CLOV as a great choice for value investors due to recent strong momentum and reasonable prices might have attracted a lot of attention and buying interest.
• Break-even earnings for Q3 with negative surprises on earnings and positive surprises on revenue could have led to disappointment among investors, causing a sell-off and contributing to the bearish movement.
• Mixed signals from market participants, expecting momentum but receiving disappointing earnings clues, likely resulted in increased volatility and downward pressure on CLOV's stock price.

05.02.2026 - CLOV Stock was down 6.7%

• Today's downturn in Clover Health's stock (CLOV) can be linked to various factors:
• Strong revenue growth and an increase in Medicare Advantage membership were overshadowed by higher net losses and loss per share in the recent SEC 10-K filing, causing concerns among investors about the company's profitability.
• The company's aim to reach GAAP profitability by 2026, while making progress in non-GAAP profitability, has raised doubts about its financial targets.
• Efforts to expand product offerings and geographic reach, as outlined in the Form 10-K, may result in higher operating expenses and competitive challenges, prompting investor wariness.
• General market volatility in the healthcare sector or broader market conditions could have influenced market sentiment, leading some investors to approach Clover Health's stock with more caution.

22.03.2026 - CLOV Stock was up 5.2%

• The positive sentiment surrounding CLOV stock today may be linked to executives having shares withheld for tax obligations related to the vesting of restricted stock units (RSUs), signaling confidence in the company's future growth.
• Tax-related share withholding actions by top executives, including the CEO, CFO, and Chief Legal Officer, may have bolstered investor trust in the leadership team's dedication to long-term success, boosting investor confidence and elevating the stock price.
• These transactions reflect transparency and adherence to tax regulations, potentially boosting the company's reputation and credibility with investors and stakeholders, fueling the bullish market movement in CLOV stock today.

06.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV stock could be attributed to the positive sentiment generated by executives receiving significant RSU grants, indicating confidence in the company's future performance and growth prospects.
• The announcement of the CFO transition and the reaffirmation of the 2026 financial outlook might have also contributed to investor optimism, showcasing stability and strategic planning within the company.
• The consistent vesting schedule of RSUs for key executives like Brady Patrick Priest, Karen Soares, Jamie L. Reynoso, and Wai Conrad, highlights a long-term commitment to the company's success, instilling trust among shareholders and potential investors.
• Overall, these developments suggest a positive outlook for Clover Health, reinforcing investor confidence and driving the bullish movement in CLOV stock.

03.01.2026 - CLOV Stock was down 5.6%

• The bearish movement in CLOV stock today may be linked to the upcoming release of its fourth quarter and full year 2025 financial results. Investors seem cautious about the company's performance, resulting in a sell-off of shares ahead of the announcement. Market sentiment appears to be affected by concerns about Clover Health Investments, Corp.'s financial health and growth prospects.

24.02.2026 - CLOV Stock was down 6.5%

• Today's bearish movement in Clover Health's stock (CLOV) could be linked to a series of insider selling activities by top executives, such as CEO Jamie L. Reynoso and General Counsel Karen Soares. This may be perceived by the market as a lack of confidence in the company's future performance, resulting in a negative investor sentiment.
• Executives' automatic withholding of shares to cover tax obligations from RSU vesting might suggest potential cash flow issues or personal financial commitments, which could further affect investor confidence in the stock.
• In summary, insider selling paired with tax-related share withholding likely contributed to the stock's bearish performance today, as investors react to signs of potential internal issues within the company.

13.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV's stock could be attributed to the positive sentiment generated by recent filings of beneficial ownership by key executives, including the VP of Finance, interim CFO, and CEO of Medicare Advantage.
• Disclosure of significant share ownership and RSUs by these executives indicates their confidence in the company's future performance, likely appealing to investors.
• The CEO of Medicare Advantage using vested shares to cover tax obligations demonstrates commitment to long-term growth, which could enhance investor trust and optimism in CLOV's prospects.
• The various ownership disclosures and transactions by key executives at Clover Health Investments probably played a role in today's bullish movement in CLOV's stock.